ATE319715T1 - Antikonvulsive pseudofructopyranose sulfamate - Google Patents

Antikonvulsive pseudofructopyranose sulfamate

Info

Publication number
ATE319715T1
ATE319715T1 AT95904333T AT95904333T ATE319715T1 AT E319715 T1 ATE319715 T1 AT E319715T1 AT 95904333 T AT95904333 T AT 95904333T AT 95904333 T AT95904333 T AT 95904333T AT E319715 T1 ATE319715 T1 AT E319715T1
Authority
AT
Austria
Prior art keywords
pseudofructopyranose
sulfamates
anticonvulsive
disclosed
compound
Prior art date
Application number
AT95904333T
Other languages
English (en)
Inventor
Michael J Costanzo
Bruce E Maryanoff
David F Mccomsey
Samuel O Nortey
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/337,597 external-priority patent/US5498629A/en
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Application granted granted Critical
Publication of ATE319715T1 publication Critical patent/ATE319715T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D497/00Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D497/02Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D497/04Ortho-condensed systems
AT95904333T 1993-12-23 1994-12-15 Antikonvulsive pseudofructopyranose sulfamate ATE319715T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17339993A 1993-12-23 1993-12-23
US08/337,597 US5498629A (en) 1993-12-23 1994-11-10 Anticonvulsant pseudofructopyranose sulfamates

Publications (1)

Publication Number Publication Date
ATE319715T1 true ATE319715T1 (de) 2006-03-15

Family

ID=26869093

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95904333T ATE319715T1 (de) 1993-12-23 1994-12-15 Antikonvulsive pseudofructopyranose sulfamate

Country Status (13)

Country Link
EP (1) EP0736029B1 (de)
JP (1) JP3555032B2 (de)
AT (1) ATE319715T1 (de)
AU (1) AU695336B2 (de)
CA (1) CA2179733C (de)
DE (1) DE69434652T2 (de)
DK (1) DK0736029T3 (de)
ES (1) ES2260761T3 (de)
IL (1) IL112098A (de)
NZ (1) NZ277725A (de)
PT (1) PT736029E (de)
RU (1) RU2139875C1 (de)
WO (1) WO1995017406A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000061138A1 (en) * 1999-04-08 2000-10-19 Ortho-Mcneil Pharmaceutical, Inc. Anticonvulsant derivatives useful in treating chronic neurodegenerative disorders
MXPA02000924A (es) 1999-07-26 2003-07-14 Johnson & Johnson Derivados de monosacarido triciclico utiles en el tratamiento de neurodegeneracion inducida por isquemia aguda.
WO2003039563A1 (en) * 2001-11-06 2003-05-15 Ortho-Mcneil Pharmaceutical Inc. Treatment and prevention of paresthesia comprising co-therapy with anticonvulsant derivatives and potassium
US7060725B2 (en) * 2002-05-13 2006-06-13 Janssen Pharmaceutica N.V. Substituted sulfamate anticonvulsant derivatives
MY147767A (en) 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
AU2006249577A1 (en) 2005-05-20 2006-11-30 Janssen Pharmaceutica N.V. Process for preparation of sulfamide derivatives
AR058389A1 (es) 2005-12-19 2008-01-30 Janssen Pharmaceutica Nv Uso de derivados heterociclicos benzo-fusionados de sulfamida para el tratamiento de la obesidad
US8691867B2 (en) 2005-12-19 2014-04-08 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
US8937096B2 (en) 2005-12-19 2015-01-20 Janssen Pharmaceutica Nv Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
US8497298B2 (en) 2005-12-19 2013-07-30 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
US8716231B2 (en) 2005-12-19 2014-05-06 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
AU2007253814A1 (en) 2006-05-19 2007-11-29 Janssen Pharmaceutica N.V. Co-therapy for the treatment of epilepsy
EA018567B1 (ru) 2008-06-23 2013-08-30 Янссен Фармацевтика Нв Кристаллическая форма (2s)-(-)-n-(6-хлор-2,3-дигидробензо[1,4]диоксин-2-илметил)сульфамида
US8815939B2 (en) 2008-07-22 2014-08-26 Janssen Pharmaceutica Nv Substituted sulfamide derivatives
EP3079686B1 (de) * 2013-12-12 2018-10-24 Bio-Pharm Solutions Co., Ltd. Sulfamatderivatverbindung zur verwendung bei der prävention oder behandlung von epilepsie

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
US5242942A (en) * 1992-04-28 1993-09-07 Mcneilab, Inc. Anticonvulsant fructopyranose cyclic sulfites and sulfates

Also Published As

Publication number Publication date
EP0736029A1 (de) 1996-10-09
ES2260761T3 (es) 2006-11-01
AU695336B2 (en) 1998-08-13
WO1995017406A1 (en) 1995-06-29
EP0736029B1 (de) 2006-03-08
JP3555032B2 (ja) 2004-08-18
IL112098A0 (en) 1995-03-15
DE69434652D1 (de) 2006-05-04
PT736029E (pt) 2006-05-31
CA2179733C (en) 2007-03-27
CA2179733A1 (en) 1995-06-29
NZ277725A (en) 1998-04-27
IL112098A (en) 1997-07-13
DE69434652T2 (de) 2007-03-01
RU2139875C1 (ru) 1999-10-20
DK0736029T3 (da) 2006-05-15
AU1306795A (en) 1995-07-10
JPH09507070A (ja) 1997-07-15

Similar Documents

Publication Publication Date Title
SE9504661D0 (sv) New compounds
ATE36149T1 (de) Antikonvulsive sulfamatderivate.
MX9707453A (es) Derivados de quinazolina.
CY1107391T1 (el) Αρυλσυμπυκνωμενες αζαπολυκυκλικες ενωσεις
ES2125233T3 (es) Tratamiento de las infecciones retrovirales humanas con 2',3'-didesoxiinosina.
ATE319715T1 (de) Antikonvulsive pseudofructopyranose sulfamate
PT948527E (pt) Novos derivados de ciclosporina sua preparacao e composicoes farmaceuticas que os contem
IL99759A (en) Mono-fluorinated derivatives of n-propargyl-1-aminoindan, their preparation and pharmaceutical compositions containing them
DE69705300T2 (de) Cyclopropylalkansäurederivate
ES2102475T3 (es) Nuevas alquil-amidas heterociclicas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
EA200100983A1 (ru) Производные 13-метилэритромицина
PT921787E (pt) Regime de administracao de inibidores de atpase de h',k'
DK1039900T3 (da) Farmaceutisk præparat indeholdende sibutramin og orlistat
MD1560G2 (ro) Compuşi ciclici, compoziţii farmaceutice pe baza lor şi metode de tratament al infecţiilor sau bolilor provocate de retrovirusuri
LU88843I2 (fr) Ropivacaine et ses dérivés pharmaceutiquement acceptables (Naropine R)
CO4940448A1 (es) Modificacion a cristal de una sustancia de medicamento
FI934680A0 (fi) Arylmorfolin, framstaellning och anvaending
ES2160308T3 (es) Nuevos derivados amino-metil-heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
SE9504662D0 (sv) New compounds
IT1270905B (it) Composizioni farmaceutiche contenenti n-acetilcarnosina per il trattamento della cataratta
ES2086195T3 (es) Nuevos derivados pseudopeptidicos de actividad antagonista de la bradiquinina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
SE9702716D0 (sv) Substituted phenylazacycloalkanes in the treatment of cognitive disorders
ES2065855B1 (es) Procedimiento para la preparacion de nuevos derivados desoxiazafosfolipidicos con accion inhibidora de la fosfolipasa a2, nuevos derivados desoxiazafosfolipidicos obtenidos y utilizacion de los mismos.
PT989994E (pt) Derivados de estreptograminas, a sua preparacao e as composicoes que os contem
SE9203824D0 (sv) Benzofuranylimidazole derivatives a process for the preparation and therapeutical compositions containing the same

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0736029

Country of ref document: EP

REN Ceased due to non-payment of the annual fee